Groundbreaking Progress in GvHD Treatment: Tr1X Successfully Doses First Patient in TRX103 Trial
![Tr1X logo](https://nationalstemcelltherapy.com/wp-content/uploads/2024/04/Tr1X_logo_Logo.jpg)
In an exciting development for autoimmune and inflammatory disorders, Tr1X, Inc. has announced the successful dosing of the first patient in its TRX103-01 proof-of-concept trial. This trial is a significant step forward in the fight against Graft versus Host Disease (GvHD), a serious condition affecting patients undergoing mismatched hematopoietic stem cell transplantation (HSCT). TRX103 represents […]
Revolutionizing Treatment: Century Therapeutics and FUJIFILM’s Groundbreaking Alliance to Combat Autoimmune Diseases with Stem Cell Therapies
![Century Therapeutics Logo](https://nationalstemcelltherapy.com/wp-content/uploads/2023/11/Century-Therapeutics-Logo-1024x305.png)
In a significant development for the treatment of autoimmune and inflammatory diseases, Century Therapeutics, Inc., a trailblazing biotechnology company, and FUJIFILM Cellular Dynamics, Inc., a prominent developer and manufacturer of human induced pluripotent stem cells (iPSCs) and iPSC-derived cells, have announced a worldwide license agreement. This collaboration is set to advance the development and commercialization […]